NEUROTROPHIC KERATITIS
Clinical trials for NEUROTROPHIC KERATITIS explained in plain language.
Never miss a new study
Get alerted when new NEUROTROPHIC KERATITIS trials appear
Sign up with your email to follow new studies for NEUROTROPHIC KERATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye drop study tracks healing for rare corneal disease over 2.5 years
Disease control CompletedThis study followed 24 patients with a rare eye condition called neurotrophic keratitis to see if the benefits of a prescription eye drop (OXERVATE) lasted long-term. Patients had previously received up to 8 weeks of treatment and were then monitored for 30 months to check if the…
Matched conditions: NEUROTROPHIC KERATITIS
Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Eye drop trial aims to heal damaged corneas
Disease control CompletedThis study tested the safety and effectiveness of OXERVATE eye drops for treating an early stage of neurotrophic keratitis, a condition where the cornea doesn't heal properly due to nerve damage. Thirty-seven adult patients used the drops for 8 weeks and were followed for an addi…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE4 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC